[White] Announcement of the Election of Directors (Election Due to Term Expiration)

1. Date of Change: 115/06/09 2. Type of Appointment or Change (Please enter corporate director, corporate auditor, independent director, natural person director, or natural person auditor): Corporate director, independent director, natural person director 3. Title and Name of Former Incumbent: (1) Director: Meiwo Hua (Stock) Company Legal Representative Li Yili (2) Director: Li Yiling (3) Director: Meiwo Hua (Stock) Company Legal Representative Li Chengjia (4) Director: Meiwo Hua (Stock) Company Legal Representative Lai Yurou (5) Director: Huayun Limited Company Legal Representative Cai Jingzhong (6) Director: Huayun Limited Company Legal Representative Wang Mingfu (7) Director: Renyu Limited Company Legal Representative Huang Zehong (8) Director: Renyu Limited Company Legal Representative Wang Baosen (9) Independent Director: Lai Shanmei (10) Independent Director: Lin Shuilong (11) Independent Director: Wu Yongchang 4. Brief Biography of Former Incumbent: (1) Director: Meiwo Hua (Stock) Company Legal Representative Li Yili, Chairman of the Board of Directors of our company and Anke Medical (Stock) Company, Vice Chairman of the Board of Directors of Meiwo Hua (Stock) Company (2) Director: Li Yiling, Vice Chairman of the Board of Directors of our company and Anke Medical (Stock) Company (3) Director: Meiwo Hua (Stock) Company Legal Representative Li Chengjia, Chairman of the Board of Directors of Meiwo Hua (Stock) Company (4) Director: Meiwo Hua (Stock) Company Legal Representative Lai Yurou, Director and General Manager of Meiwo Hua (Stock) Company (5) Director: Huayun Limited Company Legal Representative Cai Jingzhong, Director and Senior Advisor of our company (6) Director: Huayun Limited Company Legal Representative Wang Mingfu, Director of our company (7) Director: Renyu Limited Company Legal Representative Huang Zehong, Director of our company (8) Director: Renyu Limited Company Legal Representative Wang Baosen, Director of our company (9) Independent Director: Lai Shanmei, Independent Director of our company (10) Independent Director: Lin Shuilong, Independent Director of our company (11) Independent Director: Wu Yongchang, Independent Director of our company 5. Title and Name of New Incumbent: (1) Director: Meiwo Hua (Stock) Company Legal Representative Li Yili (2) Director: Li Yiling (3) Director: Meiwo Hua (Stock) Company Legal Representative Li Chengjia (4) Director: Meiwo Hua (Stock) Company Legal Representative Lai Yurou (5) Director: Liling Investment (Stock) Company Legal Representative Li Yujia (6) Director: Liling Investment (Stock) Company Legal Representative Wang Baosen (7) Director: Huayun Limited Company Legal Representative Cai Jingzhong (8) Director: Huayun Limited Company Legal Representative Wang Mingfu (9) Director: Huang Zehong (10) Independent Director: Lin Shuilong (11) Independent Director: Lai Shanmei (12) Independent Director: Wu Yongchang (13) Independent Director: Zheng Jianxin 6. Brief Biography of New Incumbent: (1) Director: Meiwo Hua (Stock) Company Legal Representative Li Yili, Chairman of the Board of Directors of our company and Anke Medical (Stock) Company, Vice Chairman of the Board of Directors of Meiwo Hua (Stock) Company (2) Director: Li Yiling, Vice Chairman of the Board of Directors of our company and Anke Medical (Stock) Company (3) Director: Meiwo Hua (Stock) Company Legal Representative Li Chengjia, Chairman of the Board of Directors of Meiwo Hua (Stock) Company (4) Director: Meiwo Hua (Stock) Company Legal Representative Lai Yurou, Director and General Manager of Meiwo Hua (Stock) Company (5) Director: Liling Investment (Stock) Company Legal Representative Li Yujia, Director of Meiwo Hua (Stock) Company (6) Director: Liling Investment (Stock) Company Legal Representative Wang Baosen, Director of our company (7) Director: Huayun Limited Company Legal Representative Cai Jingzhong, Director and Senior Advisor of our company (8) Director: Huayun Limited Company Legal Representative Wang Mingfu, Director of our company (9) Director: Huang Zehong, Director of our company (10) Independent Director: Lin Shuilong, Independent Director of our company (11) Independent Director: Lai Shanmei, Independent Director of our company (12) Independent Director: Wu Yongchang, Independent Director of our company (13) Independent Director: Zheng Jianxin, Director and General Manager of Sanfu Medical (Stock) Company 7. Type of Change (Please enter resignation, dismissal, term expiration, death, or new appointment): Term expiration 8. Reason for Change: Comprehensive election due to term expiration 9. Number of Shares Held by New Incumbent at the Time of Appointment: (1) Director: Meiwo Hua (Stock) Company Legal Representative Li Yili: 37,737,698 shares (2) Director: Li Yiling: 196,845 shares (3) Director: Meiwo Hua (Stock) Company Legal Representative Li Chengjia: 37,737,698 shares (4) Director: Meiwo Hua (Stock) Company Legal Representative Lai Yurou: 37,737,698 shares (5) Director: Liling Investment (Stock) Company Legal Representative Li Yujia: 30,000 shares (6) Director: Liling Investment (Stock) Company Legal Representative Wang Baosen: 30,000 shares (7) Director: Huayun Limited Company Legal Representative Cai Jingzhong: 46,000 shares (8) Director: Huayun Limited Company Legal Representative Wang Mingfu: 46,000 shares (9) Director: Huang Zehong: 0 shares (10) Independent Director: Lin Shuilong: 0 shares (11) Independent Director: Lai Shanmei: 0 shares (12) Independent Director: Wu Yongchang: 0 shares (13) Independent Director: Zheng Jianxin: 0 shares 10. Former Term (e.g., xx/xx/xx ~ xx/xx/xx): 112/05/24~115/05/23 11. Date of New Appointment Effectiveness: 115/06/09 12. Rate of Change in Directors During the Same Term: Not applicable. It is a comprehensive election due to term expiration. 13. Rate of Change in Independent Directors During the Same Term: Not applicable. It is a comprehensive election due to term expiration. 14. Rate of Change in Auditors During the Same Term: Not applicable. 15. Has a change occurred in more than one-third of the directors? (Please enter yes or no): No 16. Other matters to be stated (If an event occurs or the subject of the resolution is a company with more than one public offering, this major information simultaneously meets the matter defined in Article 7, Paragraph 6 of the Securities Exchange Act Enforcement Rules that has a significant impact on shareholders' rights or securities prices): None Keyword: Major Information